Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial

• প্রধান লেখক: José Luis Hernández (লেখক), Francisco S Lozano (লেখক), Vincent Riambau (লেখক), Manuel Almendro-Delia (লেখক), Juan Cosín-Sales (লেখক), Sergi Bellmunt-Montoya (লেখক), Javier Garcia-Alegria (লেখক), Xavier Garcia-Moll (লেখক), Juan José Gomez-Doblas (লেখক), José R Gonzalez-Juanatey (লেখক), Carmen Suarez Fernández (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BioExcel Publishing Ltd, 2020-07-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Patients with peripheral artery disease (PAD) are at a high risk not only for the classical cardiovascular (CV) outcomes (major adverse cardiovascular events; MACE) but also for vascular limb events (major adverse limb events; MALE). Therefore, a comprehensive approach for these patients should incl...